Yokoyama Laboratory

Yokoyama Laboratory for Molecular Biology of Stem Cell

Cooperate with '' Tsukuba University , Japan ''

Publication in 2020

1	Chen, K-K., Minakuchi, M., Wuputra, K., Ku, C-C., Pan, J-B., Kuo, K-K., Lin, Y-C., Saito. S., Lin, C-S., and Yokoyama, K.: redoc control in the pathophysiology of Imflunza viru infection. BMC Microbiology*, accepted (2020).

2	Wuputra K., Ku, C-C., Lin Y-C., Saito, S.* and Yokoyama K.: “Prevention of tumor risks associated with the reprogramming in human pluripotent stem cells”. J Exp.* Clin. Cancer Res., 39, 100 (2020).

Ku C-C., Wuputra K., Kato K., Lin W-H., Pan J-B., Tsai S-C., Kuo C-J., Lee K-H., Lee Y-L., Lin Y-C., Saito S., Noguchi M., Nakamura Y., Miyoshi H., Eckner, R., Nagata, K., Wu, D-C., Lin C-S.*, and Yokoyama K.*; Jdp2-deficient granule cell progenitors in the cerebellum are resistant to ROS-mediated apoptosis through xCT/Slc7a11 activation. Scientific Reports, 10, 4933 (2020).

4	Saito, S., Wuputra, K., Kato, K., and Yokoyama K.; The progress in the study of reprogramming to acquire the features of stem cells in iPSCs and cancers”. Advances in stem cell biology; Induced pluripotent stem cells-novel concepts” , Book from Elsevir.

5	Wang L-T., Liu K-W., Jeng W-Y., Chiang C-M., Chai C-Y., Chiou S-S., Huang M-S., Yokoyama, K. Wang S-N., Huang S-K., and Hsu S-H.*: PCAF acetylation of ISX recruits BRD4 to promote Epithelial-Mesenchymal Transition. EMBO reports, 21, e48795 (2020).

6	Saito, S., Wuputra, K., Kato, K., and Yokoyama K.; The progress in the study of reprogramming to acquire the features of stem cells in iPSCs and cancers”. Recent Advances in iPSC technology, Springer, accepted. http://doi.org/10.1016/B97-0-12-822231-7.00002-3.